Phase 3 Pivotal Trial of NanoFlu™ in Older Adults

NCT04120194 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2654

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza, Human

Interventions

BIOLOGICAL: NanoFlu
BIOLOGICAL: Fluzone Quadrivalent

Sponsor

Novavax